Clinical Trial Update: Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland [Phase 3]

View source ↗

Summary

Phase 3 trial update on reactive focal mass drug administration for malaria elimination conducted in Swaziland, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria | Phase 3 | Status: COMPLETED